Insufficient scRNA-seq data for expression of EPHA8 at single-cell level.
Insufficient scRNA-seq data for expression of EPHA8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 98% | 179.64 | 323 / 328 | 11% | 0.30 | 20 / 178 |
adrenal gland | 44% | 145.76 | 114 / 258 | 63% | 14.46 | 144 / 230 |
spleen | 100% | 695.37 | 241 / 241 | 0% | 0 | 0 / 0 |
brain | 92% | 157.55 | 2437 / 2642 | 6% | 0.32 | 42 / 705 |
skin | 19% | 9.94 | 339 / 1809 | 10% | 0.39 | 49 / 472 |
eye | 0% | 0 | 0 / 0 | 26% | 0.65 | 21 / 80 |
prostate | 10% | 4.20 | 24 / 245 | 14% | 0.25 | 70 / 502 |
breast | 3% | 1.13 | 14 / 459 | 19% | 0.74 | 212 / 1118 |
blood vessel | 14% | 12.22 | 190 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.32 | 5 / 45 |
esophagus | 3% | 0.91 | 44 / 1445 | 7% | 0.12 | 12 / 183 |
uterus | 1% | 0.34 | 2 / 170 | 7% | 0.24 | 34 / 459 |
ovary | 3% | 1.13 | 6 / 180 | 5% | 0.11 | 20 / 430 |
stomach | 1% | 0.15 | 2 / 359 | 6% | 0.27 | 18 / 286 |
kidney | 4% | 6.47 | 4 / 89 | 1% | 0.02 | 8 / 901 |
lung | 0% | 0.05 | 1 / 578 | 5% | 0.14 | 55 / 1155 |
bladder | 0% | 0 | 0 / 21 | 5% | 0.22 | 24 / 504 |
intestine | 1% | 0.28 | 9 / 966 | 4% | 0.16 | 20 / 527 |
thymus | 4% | 1.36 | 26 / 653 | 1% | 0.01 | 4 / 605 |
muscle | 2% | 0.78 | 19 / 803 | 0% | 0 | 0 / 0 |
adipose | 1% | 0.46 | 11 / 1204 | 0% | 0 | 0 / 0 |
heart | 0% | 0.10 | 3 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
peripheral blood | 0% | 0.05 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0016322 | Biological process | neuron remodeling |
GO_0071372 | Biological process | cellular response to follicle-stimulating hormone stimulus |
GO_0031175 | Biological process | neuron projection development |
GO_0007155 | Biological process | cell adhesion |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0006929 | Biological process | substrate-dependent cell migration |
GO_0033628 | Biological process | regulation of cell adhesion mediated by integrin |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0006468 | Biological process | protein phosphorylation |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0007411 | Biological process | axon guidance |
GO_0005886 | Cellular component | plasma membrane |
GO_0031901 | Cellular component | early endosome membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0030425 | Cellular component | dendrite |
GO_0005004 | Molecular function | GPI-linked ephrin receptor activity |
GO_0005003 | Molecular function | ephrin receptor activity |
GO_0005005 | Molecular function | transmembrane-ephrin receptor activity |
GO_0019838 | Molecular function | growth factor binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | EPHA8 |
Protein name | Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) |
Synonyms | HEK3 KIAA1459 EEK |
Description | FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. The GPI-anchored ephrin-A EFNA2, EFNA3, and EFNA5 are able to activate EPHA8 through phosphorylation. With EFNA5 may regulate integrin-mediated cell adhesion and migration on fibronectin substrate but also neurite outgrowth. During development of the nervous system also plays a role in axon guidance. Downstream effectors of the EPHA8 signaling pathway include FYN which promotes cell adhesion upon activation by EPHA8 and the MAP kinases in the stimulation of neurite outgrowth (By similarity). . |
Accessions | ENST00000166244.8 [P29322-1] P29322 ENST00000374644.8 [P29322-2] |